ICDM 2026

Breakfast symposium 1 Sponsored by i-SENS Chair(s): Yong Seong Kim Friday 16 October, 08:00~08:15 Room 4

BS1-L1 Ji Yoon KimKyung Hee University, Korea: Evaluating and comparing CGM accuracy and reliability: insights from recent clinical trial

Breakfast symposium 2 Sponsored by Hyundai Pharmaceutical Chair(s): Ko Kyung Soo Friday 16 October, 08:00~08:15 Room 5

BS2-L1 Ji Hye HeoHallym University, Korea: Managing residual atherogenic dyslipidemia in patients with type 2 diabetes

Breakfast symposium 3 Sponsored by Kakao Healthcare Chair(s): Ohk-Hyun Ryu Friday 16 October, 08:15~08:30 Room 4

BS3-L1 Joonyub LeeThe Catholic University of Korea, Korea: Personalized diabetes management enabled by CGM and digital health solutions

Breakfast symposium 4 Sponsored by Jeil Pharmaceutical Chair(s): Hye Soon Kim Friday 16 October, 08:15~08:30 Room 5

BS4-L1 Jaehyun BaeHallym University, Korea: Ideal combination therapy for T2DM: SGLT-2i & TZD

Luncheon symposium 1 Sponsored by Dong-A ST Chair(s): Yong Wook Cho Friday 16 October, 12:10~12:25 Room 2

LS1-L1 Yong-ho LeeYonsei University, Korea: The role of DPP-4 inhibitors in Korean diabetes care: focusing on K-evidence

Luncheon symposium 2 Sponsored by AstraZeneca Chair(s): Young Il Kim Friday 16 October, 12:10~12:25 Room 3

LS2-L1 Soo Kyoung KimGyeongsang National University, Korea: T2D management in the CKM era: the role of combination therapy in glycemic control

Luncheon symposium 3 Sponsored by LG Chem Chair(s): Pongamorn Bunnag Friday 16 October, 12:10~12:25 Room 4

LS3-L1 Jieun LeeCHA University, Korea: Does switching within the DPP-4 inhibitor class make a real difference?: integrating Korean RWE into diabetes care

Luncheon symposium 4 Sponsored by Celltrion Chair(s): Dong Sun Kim Friday 16 October, 12:10~12:25 Room 5

LS4-L1 Eun Young LeeThe Catholic University of Korea, Korea: Time for a reappraisal: the role of TZD in T2DM

Luncheon symposium 5 Sponsored by Sanofi-Aventis Korea Chair(s): Hyoungwoo Lee Friday 16 October, 12:25~12:40 Room 2

LS5-L1 Tae Jung OhSeoul National University, Korea: Importance of timely insulin initiation: optimizing glycemic control with 2nd generation basal insulin following GLP-1 RA treatment

Luncheon symposium 6 Sponsored by Yuhan Chair(s): Hyun Jin Kim Friday 16 October, 12:25~12:40 Room 3

LS6-L1 Hae Kyung KimYonsei University, Korea: One pill, broader benefits: the early T2D journey

Luncheon symposium 7 Sponsored by Hanmi Pharmaceutical Chair(s): Jae Myung Yu Friday 16 October, 12:25~12:40 Room 4

LS7-L1 Soo LimSeoul National University, Korea: Beyond weight loss; advancing obesity management through efpeglenatide

Luncheon symposium 8 Sponsored by JW Pharmaceutical Chair(s): Kyung Ah Han Friday 16 October, 12:25~12:40 Room 5

LS8-L1 Dughyun ChoiSoonchunhyang University, Korea: Management of inadequately controlled patients with diabetes mellitus

Breakfast symposium 5 Sponsored by Korea Otsuka Pharmaceutical Chair(s): In Joo Kim Saturday 17 October, 08:00~08:15 Room 4

BS5-L1 Jae-Seung YunThe Catholic University of Korea, Korea: Phenomapping-driven antiplatelet therapy for primary prevention in diabetic patients: who gets what?

Breakfast symposium 6 Sponsored by HK inno.N Chair(s): Ki-Young Lee Saturday 17 October, 08:00~08:15 Room 5

BS6-L1 Young Sang LyuChosun University, Korea: The necessity of SGLT2i in the management of CKM syndrome

Breakfast symposium 7 Sponsored by Daiichi Sankyo Chair(s): Moon Seok Nam Saturday 17 October, 08:00~08:15 Room 6

BS7-L1 Jun Hwa HongEulji University, Korea: Beyond statins: a new era of oral lipid-lowering therapy for statin-intolerant patients

Breakfast symposium 8 Sponsored by Jinyang Pharmaceutical Chair(s): Sung Woo Ha Saturday 17 October, 08:15~08:30 Room 4

BS8-L1 Yeoree YangThe Catholic University of Korea, Korea: The clinical importance of sulfonylurea and SGLT2 inhibitor in the management of type 2 diabetes

Breakfast symposium 9 Sponsored by Boryung Chair(s): Eun Hee Koh Saturday 17 October, 08:15~08:30 Room 5

BS9-L1 Eun RohSeoul National University, Korea: Pioglitazone and SGLT2 inhibitor combination therapy in diabetes complications and MASLD

Breakfast symposium 10 Sponsored by Abbott Chair(s): Hye-Seung Jung Saturday 17 October, 08:15~08:30 Room 6

BS10-L1 Richard O'BrienUniversity of Melbourne, Australia: Fenofibrate in cardiometabolic health: clinical utility and safety in dyslipidemia management

Luncheon symposium 9 Chair(s): Ho-Sang Shon Saturday 17 October, 12:00~12:15 Room 2

LS9-L1 Luc Van GaalAntwerp University, Belgium: Importance of early T2D treatment: start earlier, success together for reaching HbA1c goals in T2D treatment

Luncheon symposium 10 Sponsored by Novo Nordisk Chair(s): Jin Ook Chung Saturday 17 October, 12:00~12:15 Room 3

LS10-L1 Ryo SuzukiTokyo Medical University, Japan: IcoSema: redefining injectable therapy for type 2 diabetes

Luncheon symposium 11 Sponsored by Bayer Chair(s): Gwanpyo Koh Saturday 17 October, 12:00~12:15 Room 4

LS11-L1 Da Hea SeoInha University, Korea: A new era of CKD and T2D management: a holistic approach with nsMRA

Luncheon symposium 12 Sponsored by Daewoong Pharmaceutical Chair(s): Sang Soo Kim Saturday 17 October, 12:00~12:15 Room 5

LS12-L1 Jonghan ChoiKonkuk University, Korea: Understanding MASLD/MASH in patients with T2DM: clinical implications with a focus on SGLT2 inhibitors and enavogliflozin

Luncheon symposium 13 Sponsored by Boehringer Ingelheim Chair(s): Sangmo Hong Saturday 17 October, 12:15~12:30 Room 2

LS13-L1 Per-Henrik GroopUniversity of Helsinki, Finland: Rethinking diabetes care: why kidney protection can no longer wait

Luncheon symposium 14 Sponsored by GSK Chair(s): Mi-Kyung Kim Saturday 17 October, 12:15~12:30 Room 3

LS14-L1 Jung Hwan ParkHanyang University, Korea: The Importance of preventing shingles in diabetic patients and the role of endocrinologist

Luncheon symposium 15 Sponsored by Chongkundang Chair(s): Young Jung Cho Saturday 17 October, 12:15~12:30 Room 4

LS15-L1 Chang Hee JungUniversity of Ulsan, Korea: The optimal combination therapy with TZD and SGLT2i

Luncheon symposium 16 Sponsored by Handok Chair(s): Kyung Wan Min Saturday 17 October, 12:15~12:30 Room 5

LS16-L1 Kyong Hye JoungChungnam National University, Korea: Exploring clinical data for hypertensive patients with diabetic kidney disease: Irbesartan+Amlodipine

구분		사전등록 Early bird (~2026년 8월 10일까지)		사전등록 Advance (~2026년 9월 11일까지)		현장등록 (2026년 10월 15일 ~ 17일)
구분		KDA회원	비회원	KDA회원	비회원	KDA회원	비회원
Full Day 등록 (10월 15일~17일)	전문의 (개원의, 교수, 봉직의, 전임의 포함)	KRW 240,000	KRW 300,000	KRW 280,000	KRW 350,000	KRW 370,000	KRW 450,000
Full Day 등록 (10월 15일~17일)	전공의, 간호사, 영양사, 사회복지사, 약사, 연구원, 운동처방사, 관련분야 교수 및 기타 (군의관 및 공중보건의 포함)	KRW 140,000	KRW 200,000	KRW 180,000	KRW 230,000	KRW 250,000	KRW 270,000
One-day 등록	전문의 (개원의, 교수, 봉직의, 전임의 포함)	KRW 150,000	KRW 180,000	KRW 170,000	KRW 210,000	KRW 220,000	KRW 270,000
One-day 등록	전공의, 간호사, 영양사, 사회복지사, 약사, 연구원, 운동처방사, 관련분야 교수 및 기타 (군의관 및 공중보건의 포함)	KRW 100,000	KRW 120,000	KRW 120,000	KRW 140,000	KRW 140,000	KRW 160,000
저녁 식사	전체	KRW 55,000
For Korean 전공의 / 의과대학생 / 대학원생(기초, 간호, 영양, 기타 관련 분야) 할인 적용		KRW 50,000 당뇨병학에 관심있는 젊은 연구자 및 전공의를 위한 할인 등록을 제공하고 있습니다. 대한당뇨병학회 회원 추천서 필수 제출 ←클릭 시, 다운로드 할인 등록은 Full-registration으로만 등록이 가능합니다.

Program details

평점안내 (For Korean)